2Scaglioni PP, Melegari M, Wands JR. Biologic properities of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame[J]. Virology, 1997, 233(2) :374-381. 被引量：1
9McMahon BJ, Holock P, Bulkow L, et al. Scrologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus[J]. Ann Intern Med,2001,135(9):759-768. 被引量：1
10Strader DB, Wright T, Thomas DL, et al. Diagnosis, management,and treatment of hepatitis C[J]. Hepatology, 2004,39(4) : 1147-1171. 被引量：1
7[5]Moriyama K, Okamoto H, Tsuda F, et al. Reduced precore transcription and enhanced core-pregenome transcription of hepatitis Bvirus DNA after replacement of the precore-core promoter with sequence associated with e antigen-seronegative persistent infections[J].Virology, 1996, 226: 269-280. 被引量：1
8[6]Scaglioni P, Melegari M, Wands JR. Biological properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame [J]. Virology, 1997, 233:374-381. 被引量：1
9Porrillo RP, Schiff ER, Daris GL, et al. A randomized, controlled thrial of interferon alfa-2b alone and after predinisone withdrawl for the treatment of chronic hepatitis B[J]. N Engl J Med, 1990,323:295-301. 被引量：1
10Chang CN, Doong SL, Zhour JH, et al. Deoxycytidine deaminase-resistant stereoisomer is the active form of ( + )-2' 3 '-dideoxy-3 '-thiacytidine inhibition of hepatitis B virus replication[ J ]. J Biol Chen, 1992,267 : 13938-13942. 被引量：1
3Keeffe EB, Zeuzem S, Koff RS, et al. Report of an international workshop: roadmap for management of patients receiving oral therapy for chronic hepatitis B [J]. Clin Gastroenterol Hepatol, 2007, 5(8):890-897. 被引量：1
4Andersson KL, Chung RT. Monitoring during and after antiviral therapy for hepatitis B[J]. Hepatology, 2009, 49(5 Suppl): S166-S173. 被引量：1
5Lee WM. Hepatitis B virus infection[J]. N Engl J Med, 1997, 337(24):1733-1745. 被引量：1
6Yuen MF. Revisiting the natural history of chronic hepatitis B: impact of new concepts on clinical management[J]. J Gastroenterol Hepatol, 2007, 22(7):973-976. 被引量：1
8Liu MC, Yu M, Zhang NL, et al. Dynamic analysis of hepatitis B virus DNA and its antigens in 2.2.15 cells[J]. J Viral Hepat, 2004, 11(2):124-129. 被引量：1
9Heijtink RA, Kruining J, Honkoop P, et al. Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B[J]. J Med Virol, 1997, 53(3):282-287. 被引量：1
